This website is intended for healthcare professionals
Respiratory Handbook

The professional's guide to product selection

Glycopyrronium - AAH Pharmaceuticals

AAH Pharmaceuticals

Description

Antimuscarinic bronchodilator.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous injection
Adult: 200 mcg every 4 hours and when required, hourly use is occasionally necessary, particularly in excessive respiratory secretions.

For the treatment of excessive respiratory secretions in palliative care by subcutaneous infusion
Adult: 0.6–1.2 mg/24 hours.

Indications

For the maintenance treatment of COPD.

Contraindications

Avoid in the case of renal impairment, pregnancy or breast feeding.

Preparations Available

Solution for injection

Sizes Available

Solution for injection
200 mcg/1 ml, 10 ampoules 

More on: Bronchodilators , Antimuscarinic bronchodilators